Institution · Aerogen (Ireland)
Most cited papers from Aerogen (Ireland)
What are the most cited papers from Aerogen (Ireland)?
The most cited paper from Aerogen (Ireland) is "36th International Symposium on Intensive Care and Emergency Medicine" (R. M. Bateman et al., 2016), with 531 citations. Next come "Magnetic core-shell nanoparticles for drug delivery by nebulization" (259) and "BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia" (174).
Showing 50 of 60 papers. Every paper with more than 27 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | 36th International Symposium on Intensive Care and Emergency Medicine R. M. Bateman et al. · Critical Care | Apr 2016 | 531 |
| 2 | Magnetic core-shell nanoparticles for drug delivery by nebulization Navin Kumar Verma, Kieran Crosbie-Staunton, Amro Satti et al. · Journal of Nanobiotechnology | 2013 | 259 |
| 3 | BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia Michael S. Niederman, Jean E. Chastre, Kevin J. Corkery et al. · Intensive Care Medicine | 6 Dec 2011 | 174 |
| 4 | Emerging role of exosomes as biomarkers in cancer treatment and diagnosis Niloofar Asadi Hanjani, Nazanin Esmaelizad, Saba Zanganeh et al. · Critical Reviews in Oncology/Hematology | 3 Dec 2021 | 128 |
| 5 | Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in Medicine James B. Fink, Stéphan Ehrmann, Jie Li et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | 12 Aug 2020 | 125 |
| 6 | Nanotechnology based therapeutics for lung disease Mohammad Doroudian, Ronan J. MacLoughlin, Fergus E. Poynton et al. · Thorax | 8 Jul 2019 | 124 |
| 7 | Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications Paul Galvin, Damien Thompson, Katie B. Ryan et al. · Cellular and Molecular Life Sciences | 20 Oct 2011 | 112 |
| 8 | Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity Lu Su, Richen Li, Sarosh Ahmed Khan et al. · Journal of the American Chemical Society | 19 Jan 2018 | 109 |
| 9 | Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro Keshav Raj Paudel, Ridhima Wadhwa, Xin Nee Tew et al. · Life Sciences | 28 Mar 2021 | 108 |
| 10 | Nanotechnology in pulmonary medicine Mohammad Doroudian, Andrew O’ Neill, Ronan Mac Loughlin et al. · Current Opinion in Pharmacology | 17 Dec 2020 | 104 |
| 11 | Nasal high flow nebulization in infants and toddlers: An in vitro and in vivo scintigraphic study François Réminiac, Laurent Vecellio, Ronan Mac Loughlin et al. · Pediatric Pulmonology | 8 Jul 2016 | 93 |
| 12 | A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles Nicola N Low, Ashish Bavdekar, Lakshmanan Jeyaseelan et al. · New England Journal of Medicine | 15 Apr 2015 | 93 |
| 13 | Polysaccharide-Based Nanomedicines Targeting Lung Cancer Asif Ahmad Bhat, Gaurav Gupta, Khalid Saad Alharbi et al. · Pharmaceutics | 13 Dec 2022 | 90 |
| 14 | Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo et al. · Pharmaceutics | 3 Apr 2023 | 74 |
| 15 | Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients Islam O.F. Moustafa, Mohammed R.A. Ali, Moataz Al Hallag et al. · Heart & Lung | 4 Sep 2017 | 68 |
| 16 | Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin Renaud Respaud, Denis Marchand, Thibaut Pelat et al. · Journal of Controlled Release | 9 May 2016 | 67 |
| 17 | Clinical outcome associated with the use of different inhalation method with and without humidification in asthmatic mechanically ventilated patients Islam O.F. Moustafa, Muhammad H.E. ElHansy, Moataz Al Hallag et al. · Pulmonary Pharmacology & Therapeutics | 20 Apr 2017 | 63 |
| 18 | Micelle-based nanoparticles with stimuli-responsive properties for drug delivery Amir Hosein Maboudi, Mitra Hosseini Lotfipour, Milad Rasouli et al. · Nanotechnology Reviews | 2024 | 62 |
| 19 | Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery Mohammad H. Azhdari, Nima Goodarzi, Mohammad Doroudian et al. · International Journal of Molecular Sciences | 3 Jun 2022 | 60 |
| 20 | Fill volume, humidification and heat effects on aerosol delivery and fugitive emissions during noninvasive ventilation Haitham Saeed, Marwa Mohsen, James B. Fink et al. · Journal of Drug Delivery Science and Technology | 21 Apr 2017 | 60 |
| 21 | Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine Barbara Holzer, Sophie B. Morgan, Yumi Matsuoka et al. · The Journal of Immunology | 27 Apr 2018 | 59 |
| 22 | Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation James A. McGrath, Andrew O’Sullivan, Gavin Bennett et al. · Pharmaceutics | 12 Feb 2019 | 58 |
| 23 | Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells Chiara De Santi et al. · Molecular Therapy | 5 Feb 2020 | 57 |
| 24 | Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells Sebastian F. Vencken, Camilla Foged, Joanne Margaret Ramsey et al. · ERJ Open Research | Apr 2019 | 56 |
| 25 | Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol Michael Thomas Neary, Lianne M. Mulder, Piotr S. Kowalski et al. · Journal of Controlled Release | 25 Jan 2024 | 55 |
| 26 | Unwinding circular RNA’s role in inflammatory pulmonary diseases Asif Ahmad Bhat, Gaurav Gupta, Ahsas Goyal et al. · Naunyn-Schmiedeberg s Archives of Pharmacology | 2 Nov 2023 | 55 |
| 27 | Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies Elena Fernández Fernández, Beatriz Santos-Carballal, Chiara De Santi et al. · Materials | 13 Jan 2018 | 55 |
| 28 | Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09 Johanneke Dinie Hemmink, Sophie B. Morgan, Mario Aramouni et al. · Veterinary Research | 20 Oct 2016 | 50 |
| 29 | Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates Sean McCarthy, Elizabeth Horgan, Areeba Ali et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | 15 Nov 2019 | 48 |
| 30 | Agarwood Oil Nanoemulsion Attenuates Cigarette Smoke-Induced Inflammation and Oxidative Stress Markers in BCi-NS1.1 Airway Epithelial Cells Gabriele De Rubis, Keshav Raj Paudel, Bikash Manandhar et al. · Nutrients | 17 Feb 2023 | 47 |
| 31 | A narrative review on trans-nasal pulmonary aerosol delivery Jie Li, James B. Fink, Ronan J. MacLoughlin et al. · Critical Care | 17 Aug 2020 | 46 |
| 32 | Effective nebulization of interferon-γ using a novel vibrating mesh Louise Sweeney, Alice Patricia McCloskey, Gerard Higgins et al. · Respiratory Research | 3 Apr 2019 | 45 |
| 33 | Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy James A. McGrath, Ciarraí O’Toole, Gavin Bennett et al. · Pharmaceutics | Jun 2019 | 44 |
| 34 | State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery Hosanna Brave, Ronan J. MacLoughlin · International Journal of Molecular Sciences | 3 Sep 2020 | 43 |
| 35 | A Silicon-based MEMS Vibrating Mesh Nebulizer for Inhaled Drug Delivery Oskar Z. Olszewski, Ronan J. MacLoughlin, Alan Blake et al. · Procedia Engineering | 2016 | 43 |
| 36 | Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo Arwen F. Altenburg, Carolien E. van de Sandt, Bobby W. S. Li et al. · Scientific Reports | 11 Aug 2017 | 42 |
| 37 | Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs Veronica Martini, Michael Hinchcliffe, Elaine Blackshaw et al. · Frontiers in Immunology | 27 Oct 2020 | 41 |
| 38 | Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy Gavin Bennett, Mary Joyce, Elena Fernández Fernández et al. · Intensive Care Medicine Experimental | 3 Apr 2019 | 39 |
| 39 | An Inhaled Matrix Metalloprotease Inhibitor Prevents Cigarette Smoke-Induced Emphysema in the Mouse Philip A. Pemberton, John S. Cantwell, Karen M. Kim et al. · COPD Journal of Chronic Obstructive Pulmonary Disease | 2005 | 39 |
| 40 | Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models Ching Leng Tan et al. · European Journal of Pharmacology | 11 Feb 2022 | 36 |
| 41 | Early-Stage Development of Novel Cyclodextrin-siRNA Nanocomplexes Allows for Successful Postnebulization Transfection of Bronchial Epithelial Cells Alan Hibbitts, Aoife O’Mahony, Éanna Forde et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | 25 Mar 2014 | 36 |
| 42 | Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs Veronica Martini, Basudev Paudyal, Tiphany Chrun et al. · The Journal of Immunology | 16 Dec 2020 | 35 |
| 43 | Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis Ahmad Z. Bahlool, Sarinj Fattah, Andrew O’Sullivan et al. · Pharmaceutics | 21 Aug 2022 | 34 |
| 44 | Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease Sarah Keep et al. · Frontiers in Immunology | 28 Mar 2022 | 34 |
| 45 | Management of Community-Acquired Pneumonia in the Home Joe Ramsdell, Georgia L. Narsavage, James B. Fink · CHEST Journal | May 2005 | 34 |
| 46 | Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects Nisha Gulati, Dinesh Kumar Chellappan, Ronan J. MacLoughlin et al. · Life Sciences | 20 Sep 2021 | 33 |
| 47 | Trial of aerosolised surfactant for preterm infants with respiratory distress syndrome Luke Anthony Jardine, Kei Lui, Helen G. Liley et al. · Archives of Disease in Childhood Fetal & Neonatal | 10 Jun 2021 | 33 |
| 48 | Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects Thomas Sécher, Elsa Bodier‐Montagutelli, Christelle Parent et al. · Pharmaceutics | 18 Mar 2022 | 32 |
| 49 | From carcinogenesis to therapeutic avenues: lncRNAs and mTOR crosstalk in lung cancer Md Sadique Hussain, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal et al. · Pathology - Research and Practice | 6 Dec 2023 | 30 |
| 50 | Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases Parteek Prasher, Mousmee Sharma, Sachin Kumar Singh et al. · Journal of Drug Delivery Science and Technology | 16 Jul 2022 | 30 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.